Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers

Abstract

The ubiquitin-like modifier (UBL) family has recently generated much interest in the scientific community, as it is implicated to play important regulatory roles via novel protein–protein modification. FAT10 (diubiquitin) belongs to this family of proteins, comprising two ubiquitin-like moieties fused in tandem, and has been implicated to be involved in the maintenance of spindle integrity during mitosis. As FAT10 may play a role in the regulation of genomic stability, we examined if there is an association between FAT10 expression and hepatocellular carcinoma (HCC) or other cancers. Northern blot analyses revealed upregulation of FAT10 expression in the tumors of 90% of HCC patients. In situ hybridization as well as immunohistochemistry utilizing anti-FAT10 antibodies localized highest FAT10 expression in the nucleus of HCC hepatocytes rather than the surrounding immune and non-HCC cells. FAT10 expression was also found to be highly upregulated in other cancers of the gastrointestinal tract and female reproductive system. In conclusion, we demonstrated upregulation of FAT10 expression in various gastrointestinal and gynecological cancers. Its overexpression is unrelated to the general increase in protein synthesis or a general immune/inflammatory response to cancer. Rather, FAT10 may modulate tumorigenesis through its reported interaction with the MAD2 spindle-assembly checkpoint protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1a
Figure 4
Figure 2
Figure 3
Figure 5
Figure 6
Figure 6

Similar content being viewed by others

References

  • Bates EE, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM, Ait-Yahia S, Briere F, Caux C, Banchereau J and Lebecque S . (1997). Eur. J. Immunol., 27, 2471–2477.

  • Biggins S, Bhalla N, Chang A, Smith DL and Murray, AW . (2001). Genetics, 159, 453–470.

  • Biggins S, Ivanovska I and Rose MD . (1996). J. Cell Biol., 133, 1331–1346.

  • Boddy MN, Howe K, Etkin LD, Solomon E and Freemont PS . (1996). Oncogene, 13, 971–982.

  • Braissant O, and, Wahli W . (1998). Biochemica, 1, 10–16.

  • Fan W, Cai W, Parimoo S, Schwarz DC, Lennon GG and Weissman SM . (1996). Immunogenetics, 44, 97–103.

  • Gemma A, Hosoya Y, Seike M, Uematsu K, Kurimoto F, Hibino S, Yoshimura A, Shibuya M, Kudoh S and Emi M . (2001). Lung Cancer, 32, 289–295.

  • He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogels-tein B . (1998). Proc. Natl. Acad. Sci. USA, 95, 2509–2514.

  • Hochstrasser M . (1996a). Cell, 84, 813–815.

  • Hochstrasser M . (1996b). Annu. Rev. Genet., 30, 405–439.

  • Hooi SC, Koenig JI, Abraczinskas DR and Kaplan LM . (1997). Brain Res. Mol. Brain Res., 51, 15–22.

  • Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD and Pause A . (1999). Proc. Natl. Acad. Sci. USA, 96, 12436–12441.

  • Iwanaga Y, Kasai T, Kibler K and Jeang KT . (2002). J. Biol. Chem., 277, 31005–31013.

  • Jentsch S and Pyrowolakis G . (2000). Trends Cell Biol., 10, 335–342.

  • Jesenberger V and Jentsch S . (2002). Nat. Rev. Mol. Cell Biol., 3, 112–121.

  • Komminoth P, Merk FB, Leav I, Wolfe HJ and Roth J . (1992). Histochemistry, 98, 217–228.

  • Lee CG, Ramachandra M, Jeang KT, Martin MA, Pastan I and Gottesman, MM . (2000). FASEB J., 14, 516–522.

  • Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR and, Weissman SM . (1999). Proc. Natl. Acad. Sci. USA, 96, 4313–4318.

  • Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV and Benezra, R . (2001). Nature, 409, 355–359.

  • Muller S, Matunis MJ and Dejean A . (1998). EMBO J., 17, 61–70.

  • Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM and Yeh ET . (1996). J. Immunol., 157, 4277–4281.

  • Pickart CM . (1997). FASEB J., 11, 1055–1066.

  • Raasi S, Schmidtke G, de Giuli R and Groettrup M . (1999). Eur. J. Immunol., 29, 4030–4036.

  • Raasi S, Schmidtke G and Groettrup M . (2001). J. Biol. Chem., 276, 35334–35343.

  • Ruffner H, Joazeiro CA, Hemmati D, Hunter T and Verma IM . (2001). Proc. Natl. Acad. Sci. USA, 98, 5134–5139.

  • Sampson DA, Wang M, Matunis MJ . (2001). J. Biol. Chem., 276, 21664–21669.

  • Shah JV and Cleveland DW . (2000). Cell, 103, 997–1000.

  • Tateishi K, Omata M, Tanaka K and Chiba T . (2001). J. Cell Biol., 155, 571–579.

  • Wang X, Jin DY, Wong YC, Cheung AL, Chun AC, Lo AK, Liu Y and Tsao SW . (2000). Carcinogenesis, 21, 2293–2297.

Download references

Acknowledgements

We are greatly indebted to Professor Chi V Dang, Department of Medicine, Johns Hopkins University School of Medicine, USA, for his invaluable guidance and advice throughout this project. We thank Dr Samuel S Chong, Department of Pediatrics and Obstetrics and Gynecology, NUS for the provision of the pCMVDsRed plasmid and critical review of the manuscript. We acknowledge the Thailand Research Fund Grant Number RSA04/2540 (to IN) and the National Cancer Center Tissue Repository in Singapore for providing HCC tissues used in this study. This work was funded by grants from the Agency for Science, Technology and Research of Singapore, through Johns Hopkins Singapore (to CGLL and LAL) as well as SingHealth Cluster Research Fund through the National Cancer Center to CGLL (BF015/2002).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caroline GL Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, C., Ren, J., Cheong, I. et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22, 2592–2603 (2003). https://doi.org/10.1038/sj.onc.1206337

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206337

Keywords

This article is cited by

Search

Quick links